Status:
ACTIVE_NOT_RECRUITING
Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP
Lead Sponsor:
Superior University
Conditions:
Stroke, Cerebral
Eligibility:
All Genders
10-50 years
Phase:
NA
Brief Summary
This Study will help to explain us that ExtracorporealShockwave therapy can reduce spasticity in Stroke Patient,help them to restore their abilities and ROM.Therapy reduces dependency rate of patient....
Detailed Description
ESWT therapy increses molecular and immunological reactions,increase blood microcirculation and neurovascularization.It enhancing the neural proliferation of neural stem cell(NSC),which shows repair i...
Eligibility Criteria
Inclusion
- 3rd stage of Stroke
Exclusion
- Non spastic CP,1st stage of Stroke,Spasticity caused by injury,Newborn
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06548321
Start Date
October 1 2023
End Date
September 30 2024
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical setups Sargodha,Lahore,BWN
Lahore, Pakistan